Increasing aspirin prescriptions for high-risk pregnant women
Official title: Aspirin Prescription For Moderate- and High-Risk Obstetric Population in Outpatient Clnic; A Quality Improvement Project.
Run by Cairo University · NCT06694233 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is trying to see if more doctors will prescribe low-dose aspirin to pregnant women at risk of preeclampsia to help prevent this serious condition.
Quick facts
| Study type | Observational |
|---|---|
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Hadiya, Ahmadi) |
| Trial ID | NCT06694233 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women with moderate to high risk factors for preeclampsia, such as a history of hypertensive disease or chronic health conditions.
✕Probably not a fit
Patients who are not at risk for preeclampsia or those who do not meet the eligibility criteria will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to improve the rates of aspirin prescriptions among outpatient clinics for women at moderate to high risk of developing preeclampsia. Preeclampsia is a serious condition that can arise during pregnancy, and low-dose aspirin has been shown to significantly reduce its occurrence and related adverse outcomes. The study will audit current prescription practices and implement strategies to ensure that eligible patients receive aspirin as a preventive measure. The focus is on women with specific risk factors, including previous hypertensive diseases, chronic conditions, and certain demographic factors.
Why it matters
Potential benefit: If successful, this study could lead to increased aspirin use, thereby reducing the incidence of preeclampsia and improving pregnancy outcomes for high-risk women.
How similar studies have gone: Previous studies have demonstrated the effectiveness of low-dose aspirin in reducing preeclampsia rates, indicating that this approach has been successful in similar contexts.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Women at high risk are those with any of the following: 1. hypertensive disease during a previous pregnancy 2. chronic kidney disease 3. autoimmune disease such as systemic lupus erythematosus or antiphospholipid syndrome 4. type 1 or type 2 diabetes 5. chronic hypertension. Women with more than one moderate risk factor, such as are: 1. nulliparity 2. age 40 years or older 3. pregnancy interval of more than 10 years 4. body mass index (BMI) of 35 kg/m2 or more at first visit 5. family history of pre-eclampsia 6. multi-fetal pregnancy. Exclusion Criteria: * None. All eligible candidates will be included.
Where it's running
-
Adan hospital
Hadiya, Ahmadi, Kuwait Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preeclampsia and normal pregnancy: retinal microcirculation using OCTA
This study tests retinal blood flow in pregnant people with preeclampsia compared to healthy pregnant people using OCTA imaging.
-
Relaxation audio during breastfeeding to help newborn growth and mom’s well-being
Researchers will test if listening to a relaxation audio during breastfeeding helps LBW babies grow and reduces maternal stress in a Ugandan setting.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Origins, features, and effects of preeclampsia on mother and baby
This project will follow pregnant women diagnosed with preeclampsia through late pregnancy, delivery, and early postpartum to collect clinical data and biological samples to see how preeclampsia affects mothers and their babies.
-
National first-trimester screening program to prevent preeclampsia in Denmark
This program will try a new first-trimester screening for pregnant women with a single pregnancy in Denmark to find those at high risk of preeclampsia and offer early prevention such as low-dose aspirin.
-
Blood protein markers and heart changes in pregnant women with preeclampsia
This study tests whether blood proteins can reveal early heart changes in pregnant women with preeclampsia and uses heart ultrasound to see how the heart changes during pregnancy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.